Thomas, Kelan

Predicting new molecular targets for known drugs

Keiser, M. J., Setola, V., Irwin, J. J., Laggner, C., Abbas, A. I., Hufeisen, S. J., Jensen, N. H., Kuijer, M. B., Matos, R. C., Tran, T. B., et al. (2009) · Nature

Computational Drug Discovery MethodsReceptor Mechanisms and Signaling

Cited by 1,667

Dextromethorphan: An update on its utility for neurological and neuropsychiatric disorders

Nguyen, L., Thomas, K. L., Lucke-Wold, B. P., Cavendish, J. Z., Crowe, M. S., & Matsumoto, R. R. (2016) · Pharmacology & Therapeutics

Treatment of Major DepressionPharmacological Receptor Mechanisms and Effects

Cited by 141

Serotonin toxicity of serotonergic psychedelics

Malcolm, B., & Thomas, K. (2022) · Psychopharmacology

Psychedelics and Drug StudiesElectroconvulsive Therapy Studies

Cited by 138

Drug-drug interactions between psychiatric medications and MDMA or psilocybin: a systematic review

Sarparast, A., Thomas, K., Malcolm, B., & Stauffer, C. S. (2022) · Psychopharmacology

Psychedelics and Drug StudiesForensic Toxicology and Drug Analysis

Cited by 88

Psilocybin-Assisted Therapy: A Review of a Novel Treatment for Psychiatric Disorders

Thomas, K., Malcolm, B., & Lastra, D. (2017) · Journal of Psychoactive Drugs

Psychedelics and Drug StudiesTreatment of Major Depression

Cited by 75